Influence of automated screening and confirmation of extended-spectrum β-lactamase-producing members of the Enterobacteriaceae on prescribing of antibiotics

References

1. Bonomo R. A. 2000; Multiple antibiotic-resistant bacteria in long-term care facilities: an emerging problem in the practice of infectious disease. Clin Infect Dis 31:1414–1422 [CrossRef]
   [Google Scholar]
2. Charlson M. E., Pompei P., Ales K. L., MacKenzie C. R. 1987; A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383 [CrossRef]
   [Google Scholar]
3. CLSI 2006 Performance Standards for Antimicrobial Susceptibility Testing , 16th Information Supplement, M100-S16 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
4. Crnich C. J., Safdar N., Robinson J., Zimmerman D. 2007; Longitudinal trends in antibiotic resistance in US nursing homes, 2000–2004. Infect Control Hosp Epidemiol 28:1006–1008 [CrossRef]
   [Google Scholar]
5. Dandekar P. K., Tetreault J., Quinn J., Nightingale C. H., Nicolau D. P. 2004; Prevalence of extended spectrum β -lactamase producing Escherichia coli and Klebsiella isolates in a large community teaching hospital in Connecticut. Diagn Microbiol Infect Dis 49:37–39 [CrossRef]
   [Google Scholar]
6. Gavin P. J., Bolden J. R., Peterson L. R., Thomson R. B. Jr 2006; Does identification of an extended-spectrum β -lactamase-producing organism by the microbiology laboratory influence patient management?. Infect Dis Clin Pract 14:81–83 [CrossRef]
   [Google Scholar]
7. Jones R. N. 2001; Resistance patterns among nosocomial pathogens. Trends over the past few years. Chest 119:397S–404S [CrossRef]
   [Google Scholar]
8. Kang C. I., Kim S. H., Park W. B., Lee K. D., Kim H. B., Kim E. C., Oh M. D., Choe K. W. 2004; Bloodstream infections due to extended-spectrum β -lactamase-producing Escherichia coli and Klebsiella pneumoniae : risk factors for mortality and treatment outcomes, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 48:4574–4581 [CrossRef]
   [Google Scholar]
9. Knaus W. A., Draper E. A., Wagner D. P., Zimmerman J. E. 1985; APACHE II: a severity of disease classification system. Crit Care Med 13:818–829 [CrossRef]
   [Google Scholar]
10. Lautenbach E., Patel J. B., Bilker W. B., Edelstein P. H., Fishman N. O. 2001; Extended-spectrum β -lactamase-producing Escherichia coli and Klebsiella pneumoniae : risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32:1162–1171 [CrossRef]
    [Google Scholar]
11. Lee S. Y., Kotapati S., Kuti J. L., Nightingale C. H., Nicolau D. P. 2006; Impact of extended-spectrum β -lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 27:1226–1232 [CrossRef]
    [Google Scholar]
12. Paterson D. L., Bonomo R. A. 2005; Extended-spectrum β -lactamases: a clinical update. Clin Microbiol Rev 18:657–686 [CrossRef]
    [Google Scholar]
13. Paterson D. L., Ko W. C., Von Gottberg A., Mohapatra S., Casellas J. M., Goossens H., Mulazimoglu L., Trenholme G., Klugman K. P. other authors 2004; Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β -lactamases. Clin Infect Dis 39:31–37 [CrossRef]
    [Google Scholar]
14. Wiener J., Quinn J. P., Bradford P. A., Goering R. V., Nathan C., Bush K., Weinstein R. A. 1999; Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517–523 [CrossRef]
    [Google Scholar]
15. Wong-Beringer A., Hindler J., Loeloff M., Queenan A. M., Lee N., Pegues D. A., Quinn J. P., Bush K. 2002; Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime. Clin Infect Dis 34:135–146 [CrossRef]
    [Google Scholar]